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FAN1 interaction with ubiquitylated PCNA
alleviates replication stress and preserves genomic
integrity independently of BRCA2
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Interstrand cross-link (ICL) hypersensitivity is a characteristic trait of Fanconi anemia (FA).
Although FANCD2-associated nuclease 1 (FAN1) contributes to ICL repair, FAN1 mutations
predispose to karyomegalic interstitial nephritis (KIN) and cancer rather than to FA. Thus, the
biological role of FAN1 remains unclear. Because fork stalling in FAN1-deﬁcient cells causes
chromosomal instability, we reasoned that the key function of FAN1 might lie in the pro-
cessing of halted replication forks. Here, we show that FAN1 contains a previously-
uncharacterized PCNA interacting peptide (PIP) motif that, together with its ubiquitin-binding
zinc ﬁnger (UBZ) domain, helps recruit FAN1 to ubiquitylated PCNA accumulated at stalled
forks. This prevents replication fork collapse and controls their progression. Furthermore, we
show that FAN1 preserves replication fork integrity by a mechanism that is distinct from
BRCA2-dependent homologous recombination. Thus, targeting FAN1 activities and its
interaction with ubiquitylated PCNA may offer therapeutic opportunities for treatment of
BRCA-deﬁcient tumors.
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FAN1 is an evolutionarily-conserved protein identiﬁed in aproteomic screen for MLH1-interacting factors1. Near its N-terminus it contains a RAD18-like CCHC zinc ﬁnger, the
so-called ubiquitin-binding zinc-ﬁnger (UBZ) domain, while a
PD-(D/E)XK motif found in a superfamily of repair nucleases is
situated close to its C-terminus2–5. FAN1 also contains a SAP
domain required for DNA binding and a TPR domain that
mediates inter-domain interactions6. Disruption of the FAN1
gene in chicken DT40 cells7, or knock-down of its mRNA by
interfering RNA2–5, resulted in a hypersensitivity to ICL-inducing
agents2–5, 7. Biochemical studies revealed FAN1 to be a 5′ ﬂap
endonuclease and a 5′ to 3′ exonuclease2–5, and structural studies
helped explain its ability to unhook ICLs through catalysing a
series of incisions separated by three nucleotides6, 8, 9.
Despite this wealth of knowledge, the biological role of FAN1
remains enigmatic. Its efﬁcient recruitment to mitomycin C
(MMC)-induced DNA damage foci by ub-FANCD2 and the
requirement of its UBZ domain in this process strongly implied a
link between FAN1 and the FA pathway. However, this predic-
tion was not substantiated by genetic data showing that FAN1
mutations segregate with KIN rather than with FA10–12. More-
over, FAN1-deﬁcient cells are generally less sensitive to ICL-
inducing agents than FA cells and, unlike FA cells, display no
growth defects under normoxic conditions7. Cells lacking FA
proteins and FAN1 are also more sensitive to treatment with ICL-
inducing agents than the single mutants7, 11. Thus, while the
contribution of FAN1 to detoxiﬁcation of exogenously-
introduced ICLs is beyond doubt, this polypeptide might
address either a subset of ICLs that are not processed by the FA
pathway, or act in concert with it to ensure rapid and efﬁcient
removal of these highly-deleterious lesions from DNA. This latter
notion is supported by recent ﬁndings demonstrating that the
sensitivity of FAN1-deﬁcient cells to MMC could be fully-rescued
by stable expression of a FAN1 variant mutated in or lacking the
RAD18-like UBZ domain. This demonstrated that, although
FAN1 can be recruited to ICLs through interaction with ub-
FANCD2, it can process them also independently of it10, 13.
Interestingly, MMC treatment of cells stably-expressing the UBZ
FAN1 mutant caused extensive chromosomal instability. This was
also observed upon treatment with hydroxyurea (HU)13 that
arrests replication forks through depletion of nucleotide pools.
The link of FAN1 to stalled replication fork processing was
independently conﬁrmed in another study, in which the nuclease
was demonstrated to cause extensive degradation of aphidicolin-
blocked replication forks in FANCD2-depleted cells14. This evi-
dence suggests that FAN1 may address replication forks blocked
not only by ICLs, but also in other ways.
One process that hinders the progression of replication forks is
the spontaneous folding of G-rich single-stranded DNA arising
during transcription or replication into G-quadruplexes (G4s),
consisting of two or more stacks of guanine quartets stabilised by
Hoogsteen hydrogen-bonds. It has been predicted that more than
700′000 sequences in the human genome have the potential to
form G4s15.
We therefore set out to test whether FAN1 might be involved
in the processing of these structures. Here, we show that FAN1
prevents fork collapse at G4s through an interaction with ubi-
quitylated PCNA (ub-PCNA) mediated by a previously-
uncharacterised PCNA interacting peptide (PIP) motif and the
UBZ domain. These results suggest that FAN1 is a novel reader of
ub-PCNA. Moreover, FAN1 enhances PCNA ubiquitylation via a
feed-forward loop, as recently described for SPRTN/DVC116. In
addition, the FAN1 PIP motif and its association with ub-PCNA
is indispensable for FAN1 localization upon exposure to UV
radiation or hydroxyurea HU. Thus, the FAN1 interaction with
ub-PCNA rather than with ub-FANCD2 ensures FAN1
recruitment to stalled replication forks. In contrast, mutation of
the FAN1 PIP motif does not affect FAN1 localization to ICLs,
thus unveiling a separation of function of the FAN1 protein
domains in different contexts. Finally, we provide evidence that
FAN1 and ub-PCNA co-operate to protect genome integrity
independently of BRCA2. Taken together, our data uncover a
novel function of FAN1 in the metabolism of replication stress.
Results
FAN1 prevents fork collapse and promotes PCNA ubiquitylation.
G-quadruplexes exist in DNA only transiently; we therefore took
advantage of a compound, S2T1-6OTD, an analog of telomestatin
referred to henceforth as aTMS, which has been recently shown
to bind G4s selectively and with high afﬁnity17. We ﬁrst set out to
learn whether aTMS caused genomic instability in our model
system, the human osteosarcoma U2OS cells. Pulse ﬁeld gel
electrophoretic (PFGE) analysis of genomic DNA isolated from
wild type (WT) cells treated with control siRNA against luciferase
(CNTL) showed that aTMS induced readily-detectable double-
strand breaks (DSBs), the number of which increased 2- to 3-fold
in cells treated with FAN1 siRNA (Fig. 1a, b). Interestingly,
siRNA-mediated knock-down of MUS81 (Fig. 1a), a nuclease of
opposite polarity to FAN1, resulted in a signiﬁcant reduction in
DSB occurrence, both in the singly- and doubly-depleted cells
(Fig. 1b). The latter results suggest that FAN1 alleviates the
genotoxicity of aTMS by directly processing a subset of G4s, but
that it also addresses intermediates generated by a MUS81-
dependent pathway. In the absence of MUS81, these inter-
mediates do not arise, which results in a substantial decrease in
DSB number. This is reminiscent of the situation in MMC-
treated mouse embryonic ﬁbroblasts lacking either one or both
proteins11. The fact that genomic DNA of aTMS-treated control
cells contained readily-detectable DSBs may indicate that the
pathway(s) responsible for repairing the FAN1- and MUS81-
dependent incisions became saturated due to the large number of
G4s induced by aTMS.
In order to learn whether FAN1 was recruited to aTMS-
stabilised G4s and whether its recruitment required the functional
UBZ- and/or nuclease domains, we used the “protein replace-
ment” method18 to generate stable U2OS cell lines, in which
FAN1 was substituted by its eGFP-tagged variants. This method
makes use of a stably-integrated vector containing two doxycy-
cline (Dox)-inducible cassettes: one expressing shRNA targeting
mRNA that encodes an endogenous protein of choice, and the
second expressing cDNA encoding the desired protein variant, in
this case FAN1 carrying the WT form of the protein, the C44A/
C47A mutations that abrogate the RAD18-like zinc ﬁnger of the
UBZ domain (UBZ*), or the nuclease-dead (ND) variant D960A/
K977A (Supplementary Fig. 1a, b). Dox treatment of these stable
cell lines leads to degradation of the mRNA encoding the
endogenous FAN1 protein and to expression of the desired
variant (Supplementary Fig. 1b).
As shown in Supplementary Fig. 1c, WT eGFP-FAN1 formed
subnuclear foci in untreated U2OS cells, predominantly those in
the S and G2 phases of the cell cycle (Supplementary Fig. 1d), as
revealed by Quantitative Image-Based Cytometry (QIBC). Upon
aTMS treatment, the number of these foci increased signiﬁcantly
(Fig. 1c–e). The eGFP-FAN1 ND variant generated substantially
fewer foci, both in untreated (Supplementary Fig. 1c, d) and
aTMS-treated cells (Fig. 1c–e), whereas the eGFP-FAN1 UBZ*
variant failed to form distinct foci and appeared to localise to the
nucleoli (Fig. 1c–e and Supplementary Fig. 1c, d). FAN1 was
previously shown to be required for the successful rescue of
halted replication forks13, 14, possibly by restraining their
progression and allowing for their repair13. In the latter study,
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the forks were arrested by HU-induced dNTP depletion and we
wanted to learn whether FAN1 played a similar role in the
metabolism of stabilized G4s. We therefore monitored DNA
synthesis and cell cycle distribution in exponentially-growing
U2OS cell lines expressing eGFP-FAN1 WT, eGFP-FAN1UBZ*
and eGFP-FAN1 ND by FACS analysis through incorporation of
5-ethynyl-2′-deoxyuridine (EdU). As seen in Fig. 1f (upper
panel), the percentage of S phase cells in the three untreated
populations was not substantially different (29–37%) and EdU
incorporation was also similar. aTMS treatment caused an almost
complete inhibition of EdU incorporation in the U2OS eGFP-
FAN1 WT line, similarly to what was reported for HU13, whereas
the lines expressing the UBZ* and ND FAN1 variants were also
affected, albeit to a substantially lesser extent (Fig. 1f, lower panel).
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Replication fork arrest is accompanied by monoubiquitylation
of FANCD2. As shown in Fig. 1g, total extracts of aTMS-treated
eGFP-FAN1 WT and eGFP-FAN1 ND cell lines contained
substantial levels of ub-FANCD2, while the protein was largely
unmodiﬁed in the U2OS eGFP-FAN1 UBZ* cells. Because fork
arrest will also cause an exchange of replication factors for repair
proteins, we studied the aTMS-induced changes in chromatin
composition of our U2OS cell lines. Interestingly, in addition to
FAN1 accumulation, we also observed that the chromatin of
eGFP-FAN1 WT cells—but not that of the other lines—contained
large amounts of monoubiquitylated PCNA (Fig. 1g and
Supplementary Fig. 1e). As PCNA ubiquitylation typically occurs
when the progression of replicative DNA polymerases is hindered
by obstacles in template DNA, our ﬁnding indicates that aTMS-
stabilised G4s hinder replication fork progression. Taken together
with the ﬁnding that the aTMS-induced eGFP-FAN1 WT foci
formed predominantly in S and G2 phases of the cell cycle
(Fig. 1d), and that U2OS cells expressing eGFP-FAN1 WT
incorporated only very limited amounts of EdU into their DNA
(Fig. 1f), our ﬁndings imply that FAN1 is involved in controlling
the progression of the replication machinery through these
lesions. This notion was supported by the ﬁnding that ub-PCNA
levels were signiﬁcantly reduced in aTMS-treated serum-starved
cells (Fig. 1h) most of which were in the G0/G1 stages of the cell
cycle.
ub-PCNA helps recruit specialized polymerases that catalyse
translesion synthesis (TLS) as part of the DNA damage tolerance
pathway19. In line with this ﬁnding, the TLS DNA polymerase
polη that acts in concert with ub-PCNA also accumulated in the
chromatin of eGFP-FAN1 WT cells upon G4s stabilization. In
contrast, another TLS polymerase, REV1, appeared to be
excluded from the chromatin of aTMS-treated cells
(Supplementary Fig. 1f).
FAN1 localization to aTMS-induced foci requires ub-PCNA.
Because FAN1 recruitment to MMC-induced foci was shown to
be dependent on FANCD22–5, we wanted to test whether the
same was true also for its recruitment to G4s and whether
FANCD2 status affected PCNA ubiquitylation. eGFP-FAN1 co-
localized with only a small subset of FANCD2 foci in the aTMS-
treated cells (Supplementary Fig. 2a). siRNA-mediated FANCD2
depletion caused only a slight reduction of PCNA ubiquitylation
(Fig. 2a) and affected the number (Fig. 2b, c and Supplementary
Fig. 2a) and the intensity (Fig. 2b, d and Supplementary Fig. 2a, b)
of the eGFP-FAN1 foci to only a limited extent. To conﬁrm that
the aTMS-induced FAN1 foci formed at blocked replication forks,
we examined their co-localisation with PCNA. In eGFP-FAN1
WT cells, FAN1 foci mostly co-localised with those formed by
PCNA (Supplementary Fig. 2c) or ub-PCNA (Fig. 2b) and this
situation was largely unaffected by knock-down of FANCD2
(Fig. 2a, b). In contrast, knock-down of RAD18 (Fig. 2a), the
ubiquitin E3 ligase that modiﬁes PCNA20–23, caused diffusion of
PCNA throughout the nucleus (Supplementary Fig. 2c) and
abrogated both the number (Fig. 2b, c and Supplementary Fig. 2c)
and the intensity (Fig. 2b, d and Supplementary Fig. 2b, c) of the
eGFP-FAN1 foci. Taken together, the above evidence implies that
FANCD2 does not act upstream of FAN1 in response to aTMS.
We therefore argued that the FAN1 UBZ domain might be
required for docking with another ubiquitylated polypeptide
bound at G4s.
As anticipated, RAD18 knock-down abrogated PCNA ubiqui-
tylation. Unexpectedly, it caused a signiﬁcant decrease in the
number of FAN1 foci in aTMS treated cells. It also affected the
number of foci under unperturbed conditions to a greater extent
than FANCD2 deﬁciency (Supplementary Fig. 2d–f). RAD18 has
been implicated in FANCD2 ubiquitylation24, 25, however, the
major substrate and distal effector of RAD18-mediated ubiqui-
tylation in DNA damage response is PCNA26. This fact and our
observations suggest that it is primarily ub-PCNA and only to a
lesser extent ub-FANCD2 that recruits FAN1 to G4s. Should this
be the case, then FAN1 accumulation at G4 sites should depend
on PCNA ubiquitylation. This hypothesis was substantiated in
U2OS cells stably expressing a Strep-HA tagged PCNA K164R
variant refractory to RAD18-dependent modiﬁcation. In these
cells, both FAN1 and PCNA failed to form subnuclear foci
following aTMS treatment (Fig. 2e, f). Moreover, the distinctive
aTMS-induced pattern of FAN1- but not FANCD2 foci
(Supplementary Fig. 2g–i), was altered in cells treated with T2
amino alcohol (T2AA) (Fig. 2g–j), a small molecule that blocks
the association between ub-PCNA and its interaction partners27.
FAN1 speciﬁcally binds to ub-PCNA via its UBZ domain. To
test whether FAN1 and PCNA interact, we incubated GST-tagged
FAN1 with puriﬁed recombinant His-tagged ub-PCNA. As
shown in Fig. 3a, GST-FAN1 speciﬁcally and effectively captured
ub-PCNA at concentrations above ~ 10 nM (Supplementary
Fig. 3a), whereas GST-FAN1 UBZ* failed to do so (Fig. 3a). His-
ub-PCNA pull-down experiments using lysates of U2OS cells
expressing eGFP-FAN1 conﬁrmed the UBZ-dependent interac-
tion between FAN1 and ub-PCNA (Supplementary Fig. 3b).
Moreover, eGFP antibody beads retrieved both modiﬁed and
unmodiﬁed forms of PCNA from extracts of aTMS-treated cells
expressing eGFP-FAN1 WT, but not eGFP-FAN1 UBZ* (Fig. 3b).
In line with this ﬁnding, interaction between FAN1 and ub-
PCNA was signiﬁcantly reduced in cells depleted of RAD18
(Fig. 3c). Taken together, these data indicate that FAN1 directly
interacts with the ubiquitylated form of PCNA and that this
interaction requires its UBZ domain.
Fig. 1 FAN1 prevents fork collapse and limits DNA synthesis by promoting PCNA ubiquitylation. a Immunoblot of extracts of U2OS cells transfected with
siRNAs against FAN1 and/or MUS81, and treated or mock-treated with aTMS (2 μM; 48 h). The antibodies used are shown on the left. The ﬁgure shows
a representative blot of three independent experiments. b PFGE of DNA isolated from cells treated as described in a was performed to visualize DSB
induction. A quantiﬁcation of three independent experiments is shown. Data are represented as mean± s.d. (n= 3). Statistical analysis was carried out
using unpaired, two-tailed t-tests. P values expressed as **(P< 0.01) or ***(P< 0.001) were considered signiﬁcant. c Representative images of U2OS cells
expressing the indicated eGFP-FAN1 variants after treatment with aTMS (2 μΜ; 24 h). Scale bar: 25 μm. d Quantitative image-based cytometry (QIBC) of
eGFP-FAN1 foci in cells from c pulse-labeled with EdU during the last 3 h of aTMS treatment. The heat map indicates the mean eGFP-FAN1 intensity per
nucleus. e Quantiﬁcation of eGFP-FAN1 foci count derived from the QIBC analysis in d. Median levels are indicated by black bars. Statistical analysis was
carried out using unpaired, two-tailed t-tests. P values expressed as ***(P< 0.001) and *(P< 0.05) were considered signiﬁcant, n= 3. f Cells as in c were
treated with EdU (1 h) and Click chemistry. EdU incorporation was evaluated by FACS. g Total cell extracts and chromatin-enriched fractions of cells as in c
were analysed by immunoblotting using the antibodies shown on the left. A representative blot of four independent experiments is shown. h Immunoblot
analysis of total cell extracts of exponentially-growing or serum-starved U2OS cells expressing the indicated eGFP-FAN1 variants following treatment as in
c. A representative blot of two independent experiments is shown
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FAN1 PIP-box confers speciﬁcity to ub-PCNA interaction.
Proteins interacting with PCNA generally contain a conserved
sequence motif known as PCNA-interacting peptide or PIP box
(Supplementary Fig. 4a), and polypeptides interacting with ub-
PCNA contain in addition also a ubiquitin-binding domain
(UBD). We therefore searched for the presence of a PIP box in
human FAN1. Sequence alignments identiﬁed a potential non-
canonical PIP box sequence located immediately upstream of the
UBZ domain that was highly conserved in evolution (Fig. 4a). To
test whether this motif was functional, we mutated I30 and F34 to
alanines (Fig. 4a) and studied the ability of this GST-FAN1 PIP*
variant to interact with PCNA and ub-PCNA in GST pull-down
experiments. As shown in Fig. 4b, GST-FAN1 WT, GST-FAN1
PIP* or GST-FAN1 UBZ* did not interact with unmodiﬁed
PCNA at the tested concentrations. In contrast, GST-FAN1 WT
bound ub-PCNA with high afﬁnity, while neither GST-FAN1
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PIP* nor GST-FAN1 UBZ* did so. This indicated that the PIP
box and the UBZ domain of FAN1 function in concert to bind
ub-PCNA.
In order to substantiate these ﬁndings in vivo, we generated a
stable U2OS cell line expressing Dox-inducible eGFP-FAN1 PIP*
(Supplementary Figs. 1b and 4b). aTMS treatment failed to
induce PCNA ubiquitylation in these cells, in contrast to cells
expressing eGFP-FAN1 WT (Fig. 4c). As in the case of the eGFP-
FAN1 UBZ* variant, mutation of the PIP box abolished the
interaction between eGFP-FAN1 and ub-PCNA in vivo (Fig. 4d)
and affected eGFP-FAN1 focus formation upon aTMS treatment
(Fig. 4e–g) as well as in unperturbed cells (Supplementary Fig. 4c,
d). eGFP-FAN1 PIP* also failed to restrain DNA synthesis as
measured by EdU incorporation (Fig. 4h), or prevent fork
collapse and DSBs accumulation in aTMS-treated cells (Fig. 4i).
The FAN1/ub-PCNA interaction helps prevent fork collapse.
The crosstalk between FAN1 and ub-PCNA at G4s was further
corroborated in U2OS cells expressing Strep-HA-tagged PCNA
WT or its non-ubiquitylatable K164R mutant. Concomitant
siRNA-mediated knock-down of endogenous PCNA and FAN1
led to a reduction of aTMS-induced PCNA ubiquitylation in cells
expressing the Strep-HA-PCNA WT (Fig. 5a, left panel). As
anticipated, no PCNA ubiquitylation was observed in cells
expressing Strep-HA-PCNA K164R (Fig. 5a, right panel). As in
U2OS cells tested above (Fig. 1b), FAN1 knock-down gave rise to
substantial genomic instability in aTMS-treated cells. Impor-
tantly, the observed DSB accumulation was substantially greater
in cells expressing Strep-HA-PCNA WT than in cells expressing
the Strep-HA-PCNA K164R variant (Fig. 5b). Interestingly,
siRNA-mediated knock-down of FAN1 and USP1 (Supplemen-
tary Fig. 5), the enzyme responsible for deubiquitylating PCNA,
caused similar genomic instability in U2OS cells, but the number
of DSBs in the double knock-down was increased approximately
two-fold (Fig. 5c), thus indicating that an increase in ub-PCNA
may worsen the genomic instability in FAN1 depleted cells.
Binding to ub-PCNA ensures UV-induced FAN1 foci formation.
G4s form on the single-stranded template strand behind the
MCM helicase. We therefore asked whether FAN1 was implicated
also in the processing of other template strand lesions, such as
UV photodimers. To this end, we irradiated the U2OS cell line
expressing eGFP-FAN1 WT with UV (30 J/m2). Like aTMS, UV
irradiation caused an increase in the number of FAN1 foci, which
mostly co-localised with those formed by PCNA (Fig. 6a). This
situation was largely unaffected by knock-down of FANCD2
(Fig. 6a–c), whereas knock-down of RAD18 resulted in a decrease
of a both the number (Fig. 6a, b) and the intensity (Fig. 6a, c) of
the eGFP-FAN1 foci. Moreover, UV-induced formation of FAN1
foci was strongly reduced in cells treated with T2AA (Fig. 6d, e)
and in cells expressing the PIP* and the UBZ* variants of the
protein (Fig. 6f–h), thus recapitulating what was observed in
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aTMS-treated cells. In contrast, UV-induced FANCD2 foci were
altered only to a limited extent (Supplementary Fig. 6a–c) upon
exposure to T2AA, thus reinforcing the notion that FANCD2
does not operate upstream of FAN1 at halted forks. Along the
same line, mutation of the PIP or the UBZ domain substantially
reduced the extent of PCNA ubiquitylation in the irradiated cells
(Fig. 6i).
MMC-induced FAN1 foci form independently of its PIP-box. A
similar scenario was recapitulated in cells exposed to brief HU
treatment, where FAN1 mutations in the PIP or UBZ domain
abrogated focus formation (Supplementary Fig. 7a–d). We also
explored the role of the FAN1 interaction with ub-PCNA in
cellular response to MMC (Fig. 7a), that blocks replication fork
progression by covalently linking the Watson and the Crick
strands, a mode of action different from aTMS, UV or HU.
Surprisingly, the eGFP-FAN1 PIP* variant, but not eGFP-FAN1
UBZ*, retained the ability to form subnuclear foci in treated cells
(Fig. 7b–d) and to bind ub-FANCD2 (Fig. 7e). This shows that
FAN1 recruitment to MMC-arrested forks does not require
PCNA ubiquitylation. Taken together, the above evidence
implicates FAN1 in the processing of arrested replication forks,
but clearly demonstrates that its mode of action varies depending
on the type of barrier it encounters.
FAN1/ub-PCNA interaction stabilizes BRCA2-deﬁcient cell
DNA. Given that knock-down of FAN1 gave rise to substantial
genomic instability following aTMS treatment, we asked whether
this instability arose as a consequence of rescue of collapsed
replication forks by BRCA2-assisted homologous recombination
(HR)28. We therefore knocked-down BRCA2 with siRNA
(Fig. 8a) and examined the genetic stability of the aTMS-treated
cells by PFGE. As shown in Fig. 8b, BRCA2 knock-down did not
signiﬁcantly increase the number of DSBs when compared to the
control treated cells. In contrast, knock-down of both FAN1 and
BRCA2 caused a substantial increase in DSB number, which was
reﬂected also in increased cell death (Fig. 8c–e). The ﬁnding that
FAN1 and BRCA2 are not epistatic in the processing of replica-
tion forks halted at G4s implies that the former protein is likely
involved in controlling the restart and stability of blocked repli-
cation forks rather than in HR. However, BRCA2 deﬁciency
causes replication stress and has been reported to lead to an
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increased use of the TLS pathway following HU treatment29.
Based on data presented above, we postulated that the ability of
FAN1 to sustain or even augment PCNA ubiquitylation might
facilitate TLS and attenuate genomic instability in BRCA2-
deﬁcient cells. We therefore examined the effect of siRNA-
mediated BRCA2 knock-down in U2OS cells expressing
eGFP-FAN1 WT, eGFP-FAN1 PIP*, eGFP-FAN1 UBZ* and
eGFP-FAN1 ND (Fig. 8f) on chromosomal stability. As shown in
Fig. 8g, h, BRCA2-depleted cells expressing the FAN1 mutants
displayed enhanced levels of chromosomal abnormality when
compared to cells expressing eGFP-FAN1 WT. Moreover, FAN1
WT limits unscheduled DNA synthesis in BRCA2-depleted cells,
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whereas the PIP*, UBZ* and ND variants, did so to a much more
limited extent (Supplementary Fig. 8). Taken together, these
ﬁndings suggest that FAN1, and speciﬁcally its interaction with
ub-PCNA, might be required to counteract elevated replication
stress levels occurring in BRCA-mutated tumors, similarly to
FANCD230, 31.
Discussion
FAN1 knock-out DT40 cells7 and cell lines in which the protein
was knocked-down2–5 were reported to be hypersensitive to cis-
platin and MMC. Because recruitment of FAN1 to nuclear foci
induced by the latter reagents appeared to be dependent on
FANCD2, search for the biological role of FAN1 has focused
primarily on the metabolism of extrinsically-induced ICLs and on
its anticipated link between FAN1 and FA. Although its invol-
vement in ICL processing is beyond doubt, the absence of FAN1
mutations in FA and the link to KIN10–12, suggested that the
protein has another function. This notion was further supported
by the ﬁnding that expression of FAN1 variants either mutated
in13 or lacking11 the UBZ domain rescued the sensitivity of
FAN1-deﬁcient cells to MMC. Recent experimental evidence
points to a role of FAN1 in the metabolism of arrested or hin-
dered replication forks, as exempliﬁed by genomic instability
arising when DNA synthesis is inhibited by aphidicolin14 or
HU13. Aphidicolin and HU block the synthesis of the template
strand through interfering with the incorporation of deox-
ycytidine or through depletion of the nucleotide pool, respec-
tively. We set out to test whether barriers on the template strand
are subject to similar criteria. Here, we demonstrate that FAN1
directly interacts with ub-PCNA at replication forks stalled at
secondary structures on the template strand and that this inter-
action requires both the UBZ domain and the newly-identiﬁed
non-canonical PIP box motif of FAN1 (Fig. 4e). This is remi-
niscent of recruitment of Y-family TLS polymerases to bulky
lesions such as UV photodimers, or of SNM1A to stalled repli-
cation forks32. Interestingly, the latter nuclease can partially
compensate for FAN1 deﬁciency in ICL repair11, which suggests
that the two proteins have a similar modus operandi.
The UBZ domain and the PIP box of FAN1 are evolutionarily
conserved from C. elegans to man (Fig. 4a), which suggests that
they may have co-evolved to cope with the increased genomic
complexity of higher organisms. While the PIP motif is not
required for FAN1 recruitment to MMC-induced damage
(Fig. 7b–d), it is needed to elicit a full function of the protein
when challenged by different lesions and structures that hinder
replication progression. Likewise, the UBZ domain has hitherto
been believed to be required solely for the interaction with ub-
FANCD2, but we show that it is also needed for ub-PCNA
binding and it is possible that it helps to mediate interactions with
other, as yet unidentiﬁed, ubiquitylated proteins. We therefore
posit that FAN1 is a general factor recruited to a variety of
structures that block replication forks. As already discussed, forks
can be arrested by ICLs, by the lack of nucleotides or by poly-
merase inhibitors, but they can also be hindered by other lesions,
ranging from abasic sites, modiﬁed bases or secondary structures
to breaks in the template strand. It is most likely that these lesions
will be processed by different sets of factors. When ub-PCNA was
discovered to recruit several different TLS polymerases to
replication-blocking lesions, it was likened to a tool belt that
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antibodies. A representative blot of two independent experiments is shown
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carried many tools, because it could not anticipate the kind of
lesion that awaited it. FAN1 may have a similar role; its PIP motif
and UBZ domain provide it with a ﬂexibility necessary to engage
in the processing of different lesions, and extend its range by
combining its enzymatic activity with multifunctional recruiting
factors such as ub-PCNA and/or ub-FANCD2. But these
interactions could also serve to restrict the access of FAN1 to
certain substrates. As a nuclease that can cleave several different
DNA structures in vitro2, 4, 6, 8, 9, its activity in vivo needs to be
closely controlled. Thus, ICL-arrested forks must be incised either
prior to33, 34 or after TLS35, and processing of replication forks
arrested through nucleotide pool depletion or polymerase
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inhibition on the nascent strand may require different cofactors
than the release of forks blocked by e.g. G4s on the template
strand. The control of the nucleolytic activity is essential, as
inappropriate incision of some lesions could cause genomic
instability rather than protect against it.
FAN1 is a reader of ub-PCNA but it also enhances PCNA
ubiquitylation. It remains to be established whether it does so by
stimulating the ubiquitylation machinery, or through inhibiting
the rate of PCNA deubiquitylation. It also remains to be estab-
lished whether the extensive ubiquitylation of PCNA induced by
aTMS or UV requires prior DNA cleavage. How FAN1 limits the
rate of DNA synthesis when fork progression is hindered [ref. 13
and this work] also requires elucidation. One possibility is that
FAN1, together with ub-PCNA, helps channel a subset of stalled
forks into the TLS pathway, which utilise polymerases with lim-
ited processivity. Support for this prediction comes from bio-
chemical studies showing that FAN1 can traverse an ICL and thus
generate a substrate for TLS8. However, other pathways, such as
template-switching26, 36–39 or alternative end-joining (AJ)40–42
might also rely on the activation of the FAN1:ub-PCNA axis.
In our ﬁrst study of FAN12 we postulated that the protein
function either in the initial incision step of ICL processing, or in
the ﬁnal, HR-mediated rescue of the collapsed replication fork.
Our biochemical evidence showing that FAN1 can traverse ICLs8
suggests that the primary function of FAN1 lies in the incision of
blocked forks. The notion is further supported by the current
ﬁnding that FAN1 and BRCA2 are not epistatic, which implies
that the intermediates generated by FAN1 do not require BRCA2
for resolution. This may be linked to the fact that FAN1 is
endowed not only with a 5′-ﬂap endonuclease function, but also
with a 5′ to 3′ exonuclease that could generate stretches of ssDNA
that are channelled into a pathway distinct from BRCA2-
dependent HR. FAN1-mediated processing of blocked replica-
tion forks thus appears to be mechanistically distinct from the FA
pathway, in which FANCD2 and BRCA2 (FANCD1) cooperate43.
How these two pathways differ on the molecular level remains to
be elucidated. But if intermediates incised by FAN1 are
ﬁrst channelled into TLS rather than HR, this would activate
RAD18-mediated PCNA ubiquitylation. Ub-PCNA would then
serve as a docking site for the recruitment of factors such as
ZRANB344, which are indispensable for the resumption of DNA
synthesis.
In conclusion, our data demonstrate that the interaction with
ub-PCNA is a key facet that regulates FAN1 function and conﬁrm
that its role outside of the FA pathway is important for genome
maintenance (Fig. 8i). The synthetic toxicity observed in the
FAN1/BRCA2 double knock-down cells and the aggravated
genomic instability of BRCA2-depleted cells expressing the FAN1
PIP*, UBZ* or ND mutants suggests that inhibition of FAN1
function in BRCA-deﬁcient cancers may cause cell lethality. This
may represent a novel cancer therapeutic opportunity that
requires further study.
Methods
Cell culture. Human osteosarcoma U2OS cells were grown in Dulbecco′s modiﬁed
Eagle′s medium (DMEM) supplemented with 10% foetal calf serum (FCS),
100 U/ml penicillin, and 100 μg ml streptomycin. Using Fugene (Roche) trans-
fection according to the manufacturer′s protocol, and hygromycin B (250 μg ml−1)
and puromycin (1 μg ml−1) for selection, we established U2OS T-REx™ cell lines
inducibly expressing shRNA-resistant forms of eGFP-FAN1: FAN1-WT (full-
length wild-type protein), FAN1-PIP* (I30A/F34A) (full length protein mutated in
the non-canonical PIP motif), FAN1-UBZ* (C44A/C47A) (full length protein
mutated in the UBZ domain), FAN1-ND (D960A/K977A) (full-length FAN1
mutated in the catalytic endonuclease motif) cloned into the pAIO vector18 car-
rying an N-terminal eGFP tag. The sequence of FAN1 was altered by site-directed
mutagenesis to become resistant to si/shFAN1 (5′-GUA AGG CUC UUU CAA
CGU A-3′). To induce shRNA expression, cells were treated with 0.1 μg ml−1
doxycycline (Dox) as indicated. U2OS T-Rex cell lines were grown in DMEM
supplemented with 10% Tet system-approved FCS, 100 U/ml penicillin, 100 μg ml−1
streptomycin, hygromycin B (250 μg ml−1) and puromycin (1 μg ml−1). Ultimately,
the cDNA integrated in the genome of U2OS T-REx cells was ampliﬁed by PCR
using the primers eGFP forward (5′ATGGTGAGCAAGGGCGAGGAG3′) and
FAN1 reverse (5′TTAGCTAAGGCTTTGGCTCTTAGCTCC3′) and analysed for
the presence of mutations by deep sequencing. U2OS cell lines stably expressing
Strep-HA-PCNA wild-type or K164R mutant were a gift from Niels Mailand
(University of Copenhagen) and obtained by selecting U2OS cells transfected with
pcDNA4/TO-Strep-HA-PCNA plasmids in a medium containing zeocin (Invi-
trogen) as described45. All cell lines were tested for mycoplasma and were con-
ﬁrmed free of contamination. The cell lines used in this study were not
authenticated and are not found in the database of commonly misidentiﬁed cell
lines that is maintained by ICLAC and NCBI BioSample.
siRNA transfections. siRNA oligos were transfected at a ﬁnal concentration of 20
nM using Lipofectamine RNAiMAX (Invitrogen). For co-depletion experiments,
each siRNAs was 10 nM. In the single depletions, the siRNA (10 nM) was co-
tarnscefected with an equal concentration of a non-targeting, luciferase siRNA
(CTNL). CNTL, FAN1, BRCA2, FANCD2, RAD18, MUS81 and USP1 siRNAs
were purchased from Microsynth and the sequences (5′ to 3′) were as follows:
CNTL (CGU ACG CGG AAU ACU UCG A), FAN1 (GUA AGG CUC UUU CAA
CGU A), BRCA2 (UUG ACU GAG GCU UGC UCA GUU), FANCD2 (CAG
AGU UUG CUU CAC UCU CUA), RAD18 (AUG GUU GUU GCC CGA GGU
UAA), PCNA 3′-UTR (AGA AUA AAG UCC AAA GUC A), MUS81
(CAGCCCUGGUGGAUCGAUA), USP1 (TCGGCAATACTTGCTATCTTATT).
Pulsed ﬁeld gel electrophoresis (PFGE). PFGE was carried out essentially as
described previously46. In brief, cells were collected by trypsinization, and agarose
plugs containing 7.5 × 105 (1.5 × 106 for 2 plugs) cells were prepared. The plugs
were then incubated in lysis buffer [100 mM EDTA, 1% (w/v) sodium lauryl sar-
cosine, 0.2% (w/v) sodium deoxycholate, 1 mg/ml proteinase K] at 37 °C for 72 h
and then washed four times in washing buffer (20 mM Tris-HCl (pH 8.0), 50 mM
EDTA) for 30 min before loading onto an agarose gel. Electrophoresis was per-
formed for 21 h at 14 °C in 0.9% (w/v) Pulsed Field-Certiﬁed Agarose (Biorad)
containing TBE-Buffer, using a Biometra Rotaphor apparatus with the following
parameters: voltage, 4 V/cm; switch time, 60–240 s; angle, 120°. The gels were
stained with ethidium bromide and analysed using a CCD camera (BioRad).
Immunoﬂuorescence microscopy. The U2OS cells were cultured on coverslips.
Nuclei were pre-extracted by incubating the coverslips with pre-extraction solution
(25 mM Hepes pH 7.4, 50 mM NaCl, 1 mM EDTA, 3 mM MgCl2, 300 mM sucrose,
0.5% Triton-X-100) for 5–10 min at 4 °C. Nuclei were then ﬁxed with 4% for-
maldehyde/PBS for 10 min at room temperature (RT). Membranes were permea-
bilized with 0.2% Triton X-100 in PBS for 5 min at 4 °C. Samples were blocked with
3% BSA/PBS and incubated with primary antibodies at RT for 2 h and with the
appropriate AlexaFluor-488 (anti-mouse A-11001 or anti-rabbit A-21206), −594
(anti-mouse A-21044 or anti-rabbit A-11012) and −647 (anti-mouse A-21239 or
Fig. 8 The FAN1/ub-PCNA interaction preserves genome integrity in BRCA2-deﬁcient cells. a Immunoblot of extracts of U2OS cells transfected with
siRNAs against FAN1 and/or BRCA2, and treated or mock-treated with aTMS (2 μM; 48 h). The antibodies used are shown on the left. A representative
blot of three independent experiments is shown. b PFGE of DNA isolated from cells treated as described in a was performed to visualize DSB induction.
Quantiﬁcation of three independent experiments is shown. Data are represented as mean± s.d. (n= 3). Statistical analysis was carried out using unpaired,
two-tailed t-tests. P values expressed as ** (P< 0.01) were considered signiﬁcant. c Cell survival of cells transfected as in a was evaluated by colony
formation assays upon exposure to aTMS (n= 3). d Colony formation assay of untreated U2OS cells transfected as in a. e Quantiﬁcation of colony
formation observed in d (n= 3). f U2OS cells stably-expressing the indicated FAN1 variant were depleted or not of BRCA2 and their total cell extracts were
analysed by immunoblotting with the indicated antibodies. A representative blot of two independent experiments is shown. g Metaphase spreads of cells
as in f were analysed for chromatid breaks and radial structures. Representative images of metaphase spreads are shown. h Quantiﬁcation of chromosomal
abnormalities observed in f. Fifty spreads were analysed per single experiment per sample. Statistical signiﬁcance (P value) was calculated using one-way
ANOVA (**** P< 0.0001). i Scheme of the FAN1:ub-PCNA interaction and its biological implications
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anti-rabbit A-21245)-conjugated secondary antibodies (1:1000) (Life Technolo-
gies). Coverslips were mounted with Vectrashield® (Vector Laboratories) con-
taining DAPI and sealed. Images were acquired on Leica Fluorescence Microscope
at 63x magniﬁcation. When Click-iT EdU staining was performed, cells were
incubated with 10 μM EdU before ﬁxation or pre-extraction, and EdU detection
was performed according to the manufacturer’s recommendations (C10340,
Thermo Fisher Scientiﬁc). Some of the immunoﬂuorescence experiments were
analysed by Quantitative Image-Based Microscopy (QIBC) as previously descri-
bed47 and within one experiment, similar cell numbers were compared for the
different conditions (at least 1000 cells).
Immunoprecipitations and western blot analyses. Total cell lysates were pre-
pared from exponentially-growing cells harvested by trypsinization. Cell pellets
were washed with cold PBS and lysed in SDS lysis buffer (10 mM TrisHCl pH 8, 1%
SDS) supplemented with protease and phosphatase inhibitors [1x complete inhi-
bitory mixture EDTA free (Roche), 1 mM sodium orthovanadate, 1 mM sodium
ﬂuoride] and N-ethylmaleimide (NEM, 20 mM), an irreversible inhibitor of all
cysteine peptidases. The lysates were sonicated and cleared by centrifugation at
12,000 x g for 10 min at 4 °C. The soluble material was collected and protein
concentrations were determined using the Lowry assay. Chromatin-derived frac-
tions were obtained with the same procedure except that nuclei were pre-extracted
by incubating cell pellets with pre-extraction buffer (25 mM Hepes pH 7.4, 50 mM
NaCl, 1 mM EDTA, 3 mM MgCl2, 300 mM sucrose, 0.5% Triton-X-100) supple-
mented with protease and phosphatase inhibitors [1x complete inhibitory mixture
EDTA free (Roche), 1 mM sodium orthovanadate, 1 mM sodium ﬂuoride] and
N-ethylmaleimide (NEM, 20 mM) for 5–10 min at 4 °C before incubation with SDS
lysis buffer. For direct loading on SDS-PAGE, lysates were heated for 5 min at
95 °C. For eGFP co-IP assays, cells were lysed in eGFP-IP buffer (100 mM NaCl,
0.2% NP-40, 1 mM MgCl2, 10% glycerol, 50 mM Tris-HCl, pH 7.5) supplemented
with phosphatase inhibitors (1 mM sodium orthovanadate, 1 mM sodium ﬂuoride),
protease inhibitors [1x complete inhibitory mixture EDTA free (Roche) and 0.1
mM PMSF], N-ethylmaleimide (20 mM) and incubated with Benzonase (Novagen)
for at least 30 min at 4 °C. After Benzonase digestion, the NaCl and EDTA con-
centrations were adjusted to 200 and 2 mM, respectively, and lysates were cleared
by centrifugation. 4 mg of lysates were incubated with eGFP-Trap agarose beads
(ChromoTek) in eGFP-IP buffer (with 200 mM NaCl and 2 mM EDTA ﬁnal
concentrations) for 1 h at 4 °C. Beads were then washed ﬁve times with eGFP-IP
buffer (with 200 mM NaCl and 2 mM EDTA ﬁnal concentrations), complexes were
boiled in SDS sample buffer and analysed by SDS–PAGE followed by immuno-
blotting. The blots were blocked with 5% non-fat powdered milk in 0.1% TBS-T
(0.1% Tween-20 in TBS) for 30 min and incubated overnight at 4 °C with primary
antibodies appropriately diluted in 0.1% TBS-T. Membranes were incubated with
the appropriate secondary antibodies conjugated with horseradish peroxidase for 1
h at room temperature. Proteins were visualized using the ECL detection system
(Western BrightTM, Advansta) imaging on a FusionSolo (Witec AG). Original
uncropped images of Western blots used in this study can be found in Supple-
mentary Fig. 9.
GST-Enrichment of FAN1. Full-length wild-type or mutated variants of human
FAN1 were cloned into a pGEX-2TK and expressed in the E. coli strain BL21.
Cultures were grown at 37 °C with shaking at 250 rpm. Protein expression was
induced at OD600 0.6 by the addition of 1 mM IPTG at 18 °C for 16–18 h using
heat-shock (30 s at 42 °C before addition of IPTG). The cells were lysed by soni-
cation in the presence of protease inhibitors and lysozyme. Bacterial pellets were
lysed in 20 mM Tri-HCl pH 8, 150 mM NaCl, 0.1% NP-40, 1 mM DTT, 2 mM
ZnCl2, 0.1 mM PMSF followed by sonication for 5 min at 72% (50% cycle) and
centrifugation for 5 min at 10,000 x g. Supernatants were incubated with Glu-
tathione Sepharose 4 Fast Flow (GE Healthcare). The bound GST-fragments were
washed with 10 bead volumes of 20 mM Tris-HCl pH 8, 150 mM NaCl, 10%
glycerol, 1 mM DTT, 2 mM ZnCl2 and 0.1 mM PMSF. GST-FAN1 proteins
immobilised on Glutathione Sepharose beads were incubated with puriﬁed ubi-
quitylated PCNA (a generous gift from, Titia Sixma, Netherlands Cancer Institute)
or unmodiﬁed PCNA (ThermoFisher).
Antibodies. Antibodies to the following proteins were used in this study: sheep
α-FAN1 (1:500, a kind gift from John Rouse, University of Dundee), rabbit
α-FANCD2 (1:5000, NB100-182, Novus Biologicals), mouse α-PCNA (1:1000,
PC10, SantaCruz), rabbit α-ubiquitylated-PCNA (1:1000, D5C7P, Cell Signaling),
mouse α-RAD18 (1:500, ab57447, Abcam), rabbit α-MLH1 (1:5000, ab92312,
Abcam), rabbit α-Polη (1:1000, ab17725, Abcam), rabbit α-REV1 (1:1000, H-300,
SantaCruz), rabbit α-GFP (1:1000, ab290, Abcam), rabbit α-LaminB1 (1:1000,
ab16048, Abcam), rabbit α-histone H2B (1:1000, ab1790, Abcam), mouse
α−MUS81 (1:1000, M1445, Sigma Aldrich), rabbit α−USP1 (1:1000, Bethyl labs.
A301-700A).
Colony-formation assay. U2OS cells were depleted of FAN1 and/or BRCA2. 36 hr
after transfection with the indicated siRNAs, the cells were seeded and 24 h later
treated or not with increasing concentrations of aTMS. Cells were cultured for
10 days at 37 °C. Colonies were stained with a crystal violet/ethanol (0.5/20%)
solution and counted.
Chromosomal instability. Metaphase spreads were prepared from U2OS cells with
the indicated genotypes. In brief, cells were treated with colcemid (Gibco)
for 2 h prior to harvesting by trypsinization. The cell pellet was resuspended in 5 ml
of a 0.075M hypotonic potassium chloride solution and incubated for 15 min at 37
°C. For ﬁxation, cells were ﬁxed in methanol/acetic acid (3:1) solution.
Fixed cells were resuspended in ﬁxative to the appropriate cell density, spread on
glass slides (Menzel-Gläser, ThermoFisher) and stained with DAPI. Fluorescent
(DAPI) images were acquired using Leica Fluorescence Microscope at 63x
magniﬁcation.
Flow cytometry analysis. EdU incorporation was analysed using the Click-iT EdU
technology (C10424, ThermoFisher) according to manufacturer’s instructions.
DNA was stained with DAPI (DNA content) and ﬂuorescece was measured on an
Attune NxT Flow Cytometer (ThermoFisher Scientiﬁc).
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors upon request.
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